Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 17.10.2024STADA Arzneimittel AG (STD)4089EBevimlar 20 mg filmom obalené tablety (tbl flm 98x20 mg (blis.PVC/PVDC/Al))16.10.2024O
 17.10.2024STADA Arzneimittel AG (STD)4099EBevimlar 15 mg filmom obalené tablety (tbl flm 28x15 mg (blis.PVC/PVDC/Al))16.10.2024O
 17.10.2024STADA Arzneimittel AG (STD)4103EBevimlar 15 mg filmom obalené tablety (tbl flm 42x15 mg (blis.PVC/PVDC/Al))16.10.2024O
 17.10.2024STADA Arzneimittel AG (STD)4109EBevimlar 15 mg filmom obalené tablety (tbl flm 98x15 mg (blis.PVC/PVDC/Al))16.10.2024O
 17.10.2024Pfizer Europe MA EEIG (PFI-BE-3)93860DIFLUCAN 150 mg (cps dur 1x150 mg (blis.PVC/Al-priehľ.))31.10.2024R
 17.10.2024GlaxoSmithKline (Ireland) Limited (GAG-IE-2)13975Flixotide 250 Inhaler N (sus inh 1x120 dávok (nád.tlak.Al))14.10.2024O
 16.10.2024STADA Arzneimittel AG (STD)5899EDabigatran-etexilát STADA Arzneimittel 150 mg tvrdé kapsuly (cps dur 180 (3x60x1) x150 mg (blis.Al/OPA/Al/PVC - jednotk.bal. - multibal.))16.10.2024U
 16.10.2024Glenmark Pharmaceuticals s.r.o. (GLM-CZ)07045Telmark 80 mg (tbl flm 98x80 mg (blis.Al/Al))15.10.2024R
 16.10.2024Glenmark Pharmaceuticals s.r.o. (GLM-CZ)07040Telmark 80 mg (tbl flm 28x80 mg (blis.Al/Al))15.10.2024R
 15.10.2024Glenmark Pharmaceuticals s.r.o. (GLM-CZ)07040Telmark 80 mg (tbl flm 28x80 mg (blis.Al/Al))23.1.2020O
 15.10.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)02113Gemliquid 40 mg/ml (con inf 1x5 ml/200 mg (liek.inj.skl.))10.10.2024R
 15.10.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)5381BAripiprazol Sandoz 15 mg orodispergovateľné tablety (tbl oro 56x15 mg (blis.papier/PET/Al/PVC/Al/OPA))10.10.2024R
 15.10.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)5782AVorikonazol Sandoz 200 mg filmom obalené tablety (tbl flm 14x200 mg (blis.PVC/PVDC/Al))10.10.2024R
 15.10.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)6382CVildagliptin/Metformin Sandoz 50 mg/1000 mg (tbl flm 60x50 mg/1000 mg (blis.PA/Al/PVC/Al))15.10.2024Z
 15.10.2024Bayer, spol. s r.o. (BAY-SK-2)30566Afrin 0,5 mg/ml nosový sprej (aer nao 1x15 ml (fľ.HDPE))15.10.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)